Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Head and Neck Cancer

Free Subscription 18.06.2018 1 Ann Thorac Surg 2 Anticancer Res 1 Br J Oral Maxillofac Surg 1 Clin Nucl Med 3 Hum Pathol 4 Int J Radiat Oncol Biol Phys 4 J Laryngol Otol 13 Oral Oncol 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Thorac Surg

1. ZHANG X, Wang Y, Qu P, Liu-Helmersson J, et al
   The Prognostic Value of Tumor Length for Cause-Specific Mortality in Resectable Esophageal Cancer.
   Ann Thorac Surg. 2018 Jun 5. pii: S0003-4975(18)30749.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

2. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
   Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
   Anticancer Res. 2018;38:3669-3675.
   PubMed     Text format     Abstract available
   
   
3. JULOORI A, Koyfman SA, Geiger JL, Joshi NP, et al
   Definitive Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Hypopharynx: Long-term Outcomes and Toxicity.
   Anticancer Res. 2018;38:3543-3549.
   PubMed     Text format     Abstract available
   
   

   
   Br J Oral Maxillofac Surg

4. YUE J, Zhuo S, Zhang H, Liu X, et al
   Long-term quality of life measured by the University of Washington QoL questionnaire (version 4) in patients with oral cancer treated with or without reconstruction with a microvascular free flap.
   Br J Oral Maxillofac Surg. 2018 Jun 7. pii: S0266-4356(18)30001.
   PubMed     Text format     Abstract available
   
   

   
   Clin Nucl Med

5. DUARTE PS, Marin JFG, De Carvalho JWA, Sapienza MT, et al
   Brain Metastasis of Medullary Thyroid Carcinoma Without Macroscopic Calcification Detected First on 68Ga-Dotatate and Then on 18F-Fluoride PET/CT.
   Clin Nucl Med. 2018 Jun 12. doi: 10.1097/RLU.0000000000002163.
   PubMed     Text format     Abstract available
   
   

   
   Hum Pathol

6. PIAO L, Yang Z, Jin J, Ni W, et al
   B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
   Hum Pathol. 2018 Jun 6. pii: S0046-8177(18)30189.
   PubMed     Text format     Abstract available
   
   
7. SHABANI N, Razaviyan J, Paryan M, Tavangar SM, et al
   Evaluation of miRNAs expression in medullary thyroid carcinoma tissue samples: miR-34a and miR-144 as promising overexpressed markers in MTC.
   Hum Pathol. 2018 Jun 6. pii: S0046-8177(18)30187.
   PubMed     Text format     Abstract available
   
   
8. SATO N, Fujishima F, Nakamura Y, Aoyama Y, et al
   Myosin 5a regulates tumor migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma: utility as a prognostic factor.
   Hum Pathol. 2018 Jun 10. pii: S0046-8177(18)30208.
   PubMed     Text format     Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

9. NANDA SS, Gandhi AK, Rastogi M, Khurana R, et al
   Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy.
   Int J Radiat Oncol Biol Phys. 2018;101:593-601.
   PubMed     Text format     Abstract available
   
   
10. WU H, Chen X, Yang X, Tao Y, et al
    Early Prediction of Acute Xerostomia During Radiation Therapy for Head and Neck Cancer Based on Texture Analysis of Daily CT.
    Int J Radiat Oncol Biol Phys. 2018 May 1. pii: S0360-3016(18)30737.
    PubMed     Text format     Abstract available
    
    
11. NG WT, Tung SY, Lee V, Ngan RKC, et al
    Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.
    Int J Radiat Oncol Biol Phys. 2018 May 2. pii: S0360-3016(18)30747.
    PubMed     Text format     Abstract available
    
    
12. XU Y, Rong X, Hu W, Huang X, et al
    Bevacizumab Monotherapy Reduces Radiation-induced Brain Necrosis in Nasopharyngeal Carcinoma Patients: A Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2018 May 2. pii: S0360-3016(18)30746.
    PubMed     Text format     Abstract available
    
    

    
    J Laryngol Otol

13. ROBINSON M, Ward L, Mehanna H, Paleri V, et al
    Provision of physiotherapy rehabilitation following neck dissection in the UK.
    J Laryngol Otol. 2018 Jun 13:1-4. doi: 10.1017/S0022215118000671.
    PubMed     Text format     Abstract available
    
    
14. HARRIS AS, Thomas RG, Passant CD
    Do patients with p16-positive oropharyngeal squamous cell carcinoma get more bone metastasis than p16-negative patients?
    J Laryngol Otol. 2018;132:429-433.
    PubMed     Text format     Abstract available
    
    
15. CHING HH, Spinner AG, Reeve NH, Wang RC, et al
    A novel technique to identify the nerve of origin in head and neck schwannomas.
    J Laryngol Otol. 2018;132:452-456.
    PubMed     Text format     Abstract available
    
    
16. HABIB A
    Management of advanced hypopharyngeal carcinoma: systematic review of survival following surgical and non-surgical treatments.
    J Laryngol Otol. 2018;132:385-400.
    PubMed     Text format     Abstract available
    
    

    
    Oral Oncol

17. HANNA GJ, Kofman ER, Shazib MA, Woo SB, et al
    Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors.
    Oral Oncol. 2018;81:1-9.
    PubMed     Text format     Abstract available
    
    
18. SALOURA V, Vougiouklakis T, Sievers C, Burkitt K, et al
    The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck.
    Oral Oncol. 2018;81:100-108.
    PubMed     Text format     Abstract available
    
    
19. LIN MC, Shueng PW, Chang WK, Mu-Hsin Chang P, et al
    Consensus and clinical recommendations for nutritional intervention for head and neck cancer patients undergoing chemoradiotherapy in Taiwan.
    Oral Oncol. 2018;81:16-21.
    PubMed     Text format     Abstract available
    
    
20. KRAEIMA J, Dorgelo B, Gulbitti HA, Steenbakkers RJHM, et al
    Multi-modality 3D mandibular resection planning in head and neck cancer using CT and MRI data fusion: A clinical series.
    Oral Oncol. 2018;81:22-28.
    PubMed     Text format     Abstract available
    
    
21. OSAZUWA-PETERS N, Arnold LD, Loux TM, Varvares MA, et al
    Factors associated with increased risk of suicide among survivors of head and neck cancer: A population-based analysis.
    Oral Oncol. 2018;81:29-34.
    PubMed     Text format     Abstract available
    
    
22. FERRIS RL, Blumenschein G Jr, Fayette J, Guigay J, et al
    Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.
    Oral Oncol. 2018;81:45-51.
    PubMed     Text format     Abstract available
    
    
23. RASMUSSEN JH, Hakansson K, Rasmussen GB, Vogelius IR, et al
    A clinical prognostic model compared to the newly adopted UICC staging in an independent validation cohort of P16 negative/positive head and neck cancer patients.
    Oral Oncol. 2018;81:52-60.
    PubMed     Text format     Abstract available
    
    
24. MOTT FE, Ferrarotto R, Nguyen T, Phan J, et al
    Nasopharyngeal carcinoma outcome with induction chemotherapy followed by concurrent chemoradiotherapy.
    Oral Oncol. 2018;81:75-80.
    PubMed     Text format     Abstract available
    
    
25. YUE Q, Zhang M, Chen Y, Zheng D, et al
    Establishment of prognostic factors in recurrent nasopharyngeal carcinoma patients who received salvage intensity-modulated radiotherapy: A meta-analysis.
    Oral Oncol. 2018;81:81-88.
    PubMed     Text format     Abstract available
    
    
26. MAIR MD, Shetty R, Nair D, Mathur Y, et al
    Depth of invasion, size and number of metastatic nodes predicts extracapsular spread in early oral cancers with occult metastases.
    Oral Oncol. 2018;81:95-99.
    PubMed     Text format     Abstract available
    
    
27. ZHAN KY, Eskander A, Kang SY, Old MO, et al
    Appraisal of the AJCC 8th edition pathologic staging modifications for HPV-positive oropharyngeal cancer, a study of the National Cancer Data Base.
    Oral Oncol. 2017;73:152-159.
    PubMed     Text format     Abstract available
    
    
28. SHARMA SJ, Wittekindt C, Knuth J, Steiner D, et al
    Intraindividual homogeneity of 18F-FDG PET/CT parameters in HPV-positive OPSCC.
    Oral Oncol. 2017;73:166-171.
    PubMed     Text format     Abstract available
    
    
29. UPADHYAY P, Gardi N, Desai S, Chandrani P, et al
    Genomic characterization of tobacco/nut chewing HPV-negative early stage tongue tumors identify MMP10 asa candidate to predict metastases.
    Oral Oncol. 2017;73:56-64.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

30. TICHY A, Kabacik S, O'Brien G, Pejchal J, et al
    The first in vivo multiparametric comparison of different radiation exposure biomarkers in human blood.
    PLoS One. 2018;13:e0193412.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: